Jeremy Kooyman

All Opinions My Own

Navigation Menu

23andMe Caves to FDA

In a blog post on December 5th, CEO of 23andMe, Anne Wojcicki stated that the company would comply with the FDA’s directive to stop offering consumers access to health-related genetic testing information while they move forward with the FDA’s regulatory process. They will still continue to provide ancestry-related genetic information and...

Read More

23andMe Goes A Few Rounds With The FDA

Every so often a little bit of juicy drama occurs in the MedTech field, ranging from lawsuits to product recalls. Most of the time the FDA gets involved by slapping a “Dangerous” label on the product in question and the company scrambles to cover their asses. 23andMe is a “personal genome service” (PGS) where customers ship saliva...

Read More